#NBC Novo Nordisk aims for FDA approval of weight loss pill
Novo Nordisk aims for FDA approval of weight loss pill
In a new study, Ozempic-maker Novo Nordisk shows that its weight loss pill could achieve the similar efficacy as injectables. Novo Nordisk’s Chief Scientific Officer says they’re expecting FDA approval for the daily pill this year. NBC News’ Emilie Ikeda has the story.
For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com
» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Subscribe to Here’s the Scoop podcast: https://ift.tt/K8HgU76
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App: https://ift.tt/91trbXm
Breaking News Alerts: https://ift.tt/kWvKxwT
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Follow NBC News on Instagram: http://nbcnews.to/InstaNBC
#WeightLoss #NovoNordisk #Pill
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信